Blue Trust’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCVX
Blue Trust's PCVX Position: Q3 2026 in Review
Blue Trust reduced its Vaxcyte (PCVX) stake by 71% in Q3 2026, selling an estimated $19.2K and leaving 135 shares worth $7.68K. The position accounts for ﹤0.01% of the portfolio, ranked #1764.
Blue Trust first reported a position in PCVX in Q3 2022 and has held it in 17 quarters since. The position peaked at $70.3K in Q2 2025. 283 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.
- Blue Trust held 135 shares of Vaxcyte worth $7.68K as of Q3 2026.
- Blue Trust sold 330 Vaxcyte shares in Q3 2026, an estimated $19.2K.
- Vaxcyte made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #1764 holding.
- Blue Trust first reported a position in Vaxcyte in Q3 2022 and has held it in 17 quarters since.
- Blue Trust's Vaxcyte position peaked at $70.3K in Q2 2025.
- 283 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.